[1] SUN Y，YIN M M，MA L L，et al. Epidemiology
of Takayasu arteritis in Shanghai：a hospital-based
study and systematic review[J]. Int J Rheum Dis，
2021，24（10）：1247-1256.
[2] JANG S Y，PARK T K，KIM D K. Survival and
causes of death for Takayasu's arteritis in Korea：a
retrospective population-based study[J]. Int J Rheum
Dis，2021，24（1）：69-73.
[3] KONG F，HUANG X，SU L，et al. Risk factors for
cerebral infarction in Takayasu arteritis：a singlecentre
case-controlled study[J/OL]. Rheumatology
（Oxford），2021，keab308[2021-09-20]. https：//doi.
org/10. 1093/rheumatology/keab308.
[4] KIM H，BARRA L. Ischemic complications in
Takayasu's arteritis：a meta-analysis[J]. Semin
Arthritis Rheum，2018，47（6）：900-906.
[5] 孔芳，黄旭，魏廉，等. 大动脉炎合并脑梗死49例临
床分析[J]. 中国卒中杂志，2020，15（12）：1306-1312.
[6] UNGPRASERT P，WIJARNPREECHA K，
CHEUNGPASITPORN W，et al. Inpatient
prevalence，burden and comorbidity of Takayasu's
arteritis：nationwide inpatient sample 2013-2014[J].
Semin Arthritis Rheum，2019，49（1）：136-139.
[7] BOOT E，EKKER M S，PUTAALA J，et
al. Ischaemic stroke in young adults：a global
perspective[J]. J Neurol Neurosurg Psychiatry，2020，
91（4）：411-417.
[8] DIRESKENELI H. Clinical assessment in Takayasu's
arteritis：major challenges and controversies[J/
OL]. Clin Exp Rheumatol，2017，35，Suppl103（1）：
189-193[2021-09-20]. PMID：28375833. http：//
www. clinexprheumatol. org/pubmed/find-pii.
asp?pii=28375833.
[9] HWANG J，KIM S J，BANG O Y，et al. Ischemic
stroke in Takayasu's arteritis：lesion patterns and
possible mechanisms[J]. J Clin Neurol，2012，8（2）：
109-115.
[10] COUTURE P，CHAZAL T，ROSSO C，et al.
Cerebrovascular events in Takayasu arteritis：a
multicenter case-controlled study[J]. J Neurol，2018，
265（4）：757-763.
[11] TOMBETTI E，DI CHIO M C，SARTORELLI
S，et al. Systemic pentraxin-3 levels reflect
vascular enhancement and progression in Takayasu
arteritis[J]. Arthritis Res Ther，2014，16（6）：479.
[12] DONG H，ZHANG Y，ZOU Y B，et al. Elevated
chemokines concentration is associated with disease
activity in Takayasu arteritis[J/OL]. Cytokine，2021，
143：155515[2021-09-20]. https：//doi. org/10. 1016/j.
cyto. 2021. 155515.
[13] SOUSSAN M，NICOLAS P，SCHRAMM C，et al.
Management of large-vessel vasculitis with FDGPET：
a systematic literature review and metaanalysis[
J/OL]. Medicine（Baltimore），2015，94
（14）：e622[2021-09-20]. https：//doi. org/10. 1097/
md. 0000000000000622.
[14] MAZ M，CHUNG S A，ABRIL A，et al. 2021
American college of rheumatology/vasculitis
foundation guideline for the management of giant
cell arteritis and Takayasu arteritis[J]. Arthritis
Rheumatol，2021，73（8）：1349-1365.
[15] JUNG J H，LEE Y H，SONG G G，et al.
Endovascular versus open surgical intervention in
patients with Takayasu's arteritis：a meta-analysis[J].
Eur J Vasc Endovasc Surg，2018，55(6):888-899.
